ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,144.15
      0.24%
      US Tech 100
      21,553.60
      -0.10%
      Dow Jones
      44,627.59
      0.16%
      Brent Oil
      75.55
      -0.36%
      Bitcoin
      96,904.51
      0.28%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Shattuck Labs Inc (STTK) Quote

      Shattuck Labs Inc

      Shattuck Labs Inc (STTK)

      NASDAQ
      1.26
      0.00
      (0.00%)
      Closed February 19 4:00PM
      Delayed by 15 minutes
      1.308
      0.048
      (3.81%)
      After Hours: 7:38PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.308
      Bid
      1.25
      Ask
      1.31
      Volume
      130,289
      1.21 Day's Range 1.28
      0.94 52 Week Range 11.76
      Market Cap
      62.444M
      Previous Close
      1.26
      Open
      1.24
      Last Trade
      5
      @
      1.3
      Last Trade Time
      Financial Volume
      $ 163,565
      VWAP
      1.2554
      Average Volume (3m)
      199,737
      Shares Outstanding
      47,739,708
      Dividend Yield
      -
      PE Ratio
      -0.69
      Earnings Per Share (EPS)
      -1.83
      Revenue
      1.66M
      Net Profit
      -87.3M

      About Shattuck Labs Inc

      Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restor... Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.shattucklabs.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Shattuck Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker STTK. The last closing price for Shattuck Labs was $1.26. Over the last year, Shattuck Labs shares have traded in a share price range of $ 0.94 to $ 11.76.

      Shattuck Labs currently has 47,739,708 shares outstanding. The market capitalization of Shattuck Labs is $60.15 million. Shattuck Labs has a price to earnings ratio (PE ratio) of -0.69.

      Ask ADVFN Intelligence (AI)

      STTK Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 28 2025
      STTK (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 28 2025
      STTK (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 28 2025
      STTK (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 28 2025
      STTK (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 13 2025
      STTK (0.00%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.12810.84745762711.181.361.15967371.2701631CS
      40.15813.73913043481.151.361.11190531.21957631CS
      120.24823.39622641511.061.391.021997371.20432999CS
      26-2.062-61.18694362023.373.950.943892791.60701248CS
      52-8.002-85.95059076269.3111.760.943888584.1650213CS
      156-3.452-72.52100840344.7611.760.943262124.85679057CS
      260-17.302-92.971520687818.6160.51620.942916049.09732894CS

      STTK - Frequently Asked Questions (FAQ)

      What is the current Shattuck Labs share price?
      The current share price of Shattuck Labs is $ 1.308
      How many Shattuck Labs shares are in issue?
      Shattuck Labs has 47,739,708 shares in issue
      What is the market cap of Shattuck Labs?
      The market capitalisation of Shattuck Labs is USD 60.15M
      What is the 1 year trading range for Shattuck Labs share price?
      Shattuck Labs has traded in the range of $ 0.94 to $ 11.76 during the past year
      What is the PE ratio of Shattuck Labs?
      The price to earnings ratio of Shattuck Labs is -0.69
      What is the cash to sales ratio of Shattuck Labs?
      The cash to sales ratio of Shattuck Labs is 36.31
      What is the reporting currency for Shattuck Labs?
      Shattuck Labs reports financial results in USD
      What is the latest annual turnover for Shattuck Labs?
      The latest annual turnover of Shattuck Labs is USD 1.66M
      What is the latest annual profit for Shattuck Labs?
      The latest annual profit of Shattuck Labs is USD -87.3M
      What is the registered address of Shattuck Labs?
      The registered address for Shattuck Labs is 108 LAKELAND AVE, DOVER, DELAWARE, 19901
      What is the Shattuck Labs website address?
      The website address for Shattuck Labs is www.shattucklabs.com
      Which industry sector does Shattuck Labs operate in?
      Shattuck Labs operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      JTAIJet AI Inc
      $ 10.1006
      (148.78%)
      		149.38M
      EDITEditas Medicine Inc
      $ 3.19
      (83.33%)
      		49.89M
      SINTSiNtx Technologies Inc
      $ 4.79
      (69.86%)
      		70.97M
      LYTLytus Technologies Holdings PTV Ltd
      $ 0.363
      (63.07%)
      		215.48M
      AGHAureus Greenway Holdings Inc
      $ 3.8501
      (42.07%)
      		1.02M
      CNSPCNS Pharmaceuticals Inc
      $ 0.0838
      (-41.19%)
      		88.17M
      HCTIHealthcare Triangle Inc
      $ 0.4409
      (-38.76%)
      		3.19M
      NKLANikola Corporation
      $ 0.4711
      (-38.49%)
      		110.5M
      BPTHBio Path Holdings Inc
      $ 0.1322
      (-37.05%)
      		2.14M
      GLSTUGlobal Star Acquisition Inc
      $ 7.26
      (-36.04%)
      		4.41k
      ADTXAditxt Inc
      $ 0.1288
      (17.09%)
      		612.1M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0616
      (13.03%)
      		482.51M
      SMCISuper Micro Computer Inc
      $ 60.25
      (7.97%)
      		338.03M
      LYTLytus Technologies Holdings PTV Ltd
      $ 0.363
      (63.07%)
      		215.48M
      NVDANVIDIA Corporation
      $ 139.23
      (-0.12%)
      		168.02M

      STTK Discussion

      View Posts
      TrendTrade2016 TrendTrade2016 4 months ago
      STTK COMING OFF BOTTOM
      👍️0
      glenn1919 glenn1919 4 months ago
      STTK............................https://stockcharts.com/h-sc/ui?s=STTK&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 6 months ago
      STTK under $4
      👍️0
      PonkenPlonken PonkenPlonken 9 months ago
      absolutely revolutionary data in HR MDS... compare to SOC!!! HMAs show a ORR 30%, CR 10-20%
      (also beats venetoclax + HMA in TP53m AML)

      Observed 79% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete response (CR)/marrow complete response (mCR) rate of 64% –

      – Observed 27% initial CR/complete response with incomplete hematologic recovery (CRi) in frontline TP53m AML patients, and 5/11 evaluable patients achieved stable disease with decreasing blast counts and peripheral blood count improvement, these patients continue on treatment
      👍️0
      Monksdream Monksdream 10 months ago
      STTK new 52 week high
      👍️0
      Monksdream Monksdream 1 year ago
      STTK new 52 week high
      👍️0
      Monksdream Monksdream 1 year ago
      STTK new 52 week low
      👍️0
      tbonaces80 tbonaces80 1 year ago
      Takeda gonna tender on next trial fast track
      👍️0
      tbonaces80 tbonaces80 1 year ago
      load it-going to 10+
      👍️0
      subslover subslover 1 year ago
      No fooling? So you say a 1.75% profit for a two-hour trade is a bad trade?
      👍️0
      tbonaces80 tbonaces80 1 year ago
      Bad trade
      👍️0
      subslover subslover 1 year ago
      Ok. I got out of this POS this morning at $5.00, got lucky is all
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      @ 4.29 I was just looking for a move under $4 and it did

      small gain, but I didnt know how many borrows I could get if it went against me

      sometimes I go short, and get upside down and cant average up, because broker all of a sudden has NO available shares to short= your stuck

      so thats why I dont short much
      👍️0
      subslover subslover 1 year ago
      What price did you short?tia
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      I shorted it... Its just Phase 1

      AI bot hyper extended the POP

      I used to chase these Pase 1 rallys, lost lots of money doing so

      some of my biggest losses ever

      Phase 1 Gap & Traps
      👍️0
      subslover subslover 1 year ago
      Did you see this open? $7.28! then immediately dropped down to $2.50 omg. I'm in at $3.00 just hoping for the best. Worth a shot
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      https://twitter.com/TigerLineTrades/status/1734900423301988796
      👍️0
      subslover subslover 1 year ago
      $TSOI's new Introducing the ALScell™, also known as the JadiCell™ – Now, these ALScells are not your run-of-the-mill mesenchymal stem cells; they're basically the overachievers of the cellular world. These ALScells have it all – enhanced growth factor production, like they've been hitting the gym and drinking protein shakes on a regular basis. They can secrete exosomes , outshining their stem cell peers who are still trying to figure out how to tie their cellular shoelaces.

      But wait, there's more! These ALScells are not just content with being academically gifted; they've got some serious street smarts too. Superior angiogenic and neurogenic abilities mean they're like the cool kids who not only excel in science class but also throw legendary parties in the cellular neighborhood.

      And guess what? Exosomes are not just a fancy word; they're the VIP pass to the cure of many cancers. It's like the ALScells are hosting the party, and exosomes are the invitations that cancer cells can't resist.

      So, say hello to the ALScell™ – the cellular superhero ready to save the day, one enhanced growth factor at a time, and unlocking cures like a boss!
      Bullish
      BULLISH
      👍️0
      Awl416 Awl416 1 year ago
      Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Pati
      👍️0
      Monksdream Monksdream 1 year ago
      STTK under $2
      👍️0

      Your Recent History

      NASDAQ
      STTK
      Shattuck Labs
      EU
      CRI
      Chargeurs
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads